Career Opportunities for Pharmacists in the Pharmaceutical Industry

Speaker: Alan Parr

Affiliation: BioCeutics, LLC

Event Details: Dr. Parr has worked in the field of Pharmaceutical Sciences for ~40 years. Most of this time has been spent in the big pharma sector (Glaxo, GlaxoWellcome and GlaxoSmithKline). Dr. Parr’s roles in big pharma including included formulation scientist, formulation manager, and Director of Biopharmaceutics and responsibilities ranged from development of formulations from the early development phase all the way through to the scale up of commercial size batches for the marketplace. Specific activities during this time included physical property characterization, formulation screening, formulation development, manufacture of clinical supplies, transfer of product to production and overall project management. He was intimately involved with the creation, review and submission of regulatory documents to the US Food and Drug Administration, including Investigational New Drug (IND) applications, New Drug Applications (NDA) as well as foreign filings (Marketing Authorization Applications (MAA)). Since June of 2015 Dr. Parr as served as consultant to numerous small pharmaceutical companies and has served as principal investor for 3 NIH grants where his primary responsibility was to file an IND for an NCE that was being developed. Dr. Parr earned his Pharm.D. degree from the University of Nebraska College of Pharmacy in 1981 and his Ph.D. from the University of Kentucky College of Pharmacy in 1986.

The Spring 2024 Series will be in-person (in MUFW 136) and/or live-streamed. All sessions will be recorded. To access a recording of the session, please contact Dr. Wei Lei (wlei@manchester.edu)